Evaluation of withacoagulin from Withania coagulans for glycemic improvement and β-cell preservation in a type 2 diabetic model. // Advances in Biomarker Sciences and Technology. – URL: https://www.sciencedirect.com/science/article/pii/S2543106425000481?dgcid=rss_sd_all
Evaluation of withacoagulin from Withania coagulans for glycemic improvement and β-cell preservation in a type 2 diabetic model. Advances in Biomarker Sciences and Technology. https://www.sciencedirect.com/science/article/pii/S2543106425000481?dgcid=rss_sd_all
“Evaluation of withacoagulin from Withania coagulans for glycemic improvement and β-cell preservation in a type 2 diabetic model.” Advances in Biomarker Sciences and Technology.
@article{article33291,
title = {Evaluation of withacoagulin from Withania coagulans for glycemic improvement and β-cell preservation in a type 2 diabetic model},
journal = {Advances in Biomarker Sciences and Technology},
url = {https://www.sciencedirect.com/science/article/pii/S2543106425000481?dgcid=rss_sd_all}
}
ABSTRACT Three‐dimensional (3D) printing enables precise control over scaffold geometry, porosity, material distribution, and spatial delivery of cells and bioactive cues. However, features intended to improve biological fidelity often...